Press Releases

1. The Government of Japan decided to extend Emergency Grant Aid of approximately 4.66 million US dollars to cover a part of the logistics costs, including the cost of transportation, related to the donation of approximately 11 million doses of COVID-19 vaccines manufactured in Japan, which are planned to be provided through the COVAX facility to 15 countries in Southeast Asia, Southwest Asia, Pacific Island Countries, and others. This assistance will be provided to the United Nations Office for Project Services (UNOPS), who is responsible for logistical support including transportation of the vaccines.
2. In order to overcome COVID-19, it is important to promote equitable access to vaccines not only in Japan but also throughout the world. Japan will continue to work towards securing equitable access to safe, effective and quality-assured vaccines through various support, responding to the needs of developing countries and the world, in cooperation with relevant countries and international organizations.

[Note 1] COVAX Facility (COVID-19 Vaccine Global Access Facility)

The COVAX Facility is a comprehensive mechanism for resource mobilization and supply coordination led by Gavi, and operated in cooperation with WHO, UNICEF and CEPI. It aims to secure equitable access to vaccines regardless of income levels. COVAX enables supply of COVID-19 vaccines swiftly at an affordable price, leveraging economies of scale through guaranteeing purchase and market demand for vaccine.

[Note 2] Breakdown of planned donation of COVID-19 vaccines manufactured in Japan through the COVAX Facility (subject to change depending on final coordination)

Cambodia (approximately 1,000,000 doses), Laos (approximately 600,000 doses), Timor-Leste (approximately 170,000 doses), Bangladesh (approximately 2,900,000 doses), Maldives (approximately 100,000 doses), Nepal (approximately 1,600,000 doses), Sri Lanka (approximately 1,500,000 doses), Fiji (approximately 60,000 million doses), Kiribati (approximately 60,000 doses), Papua New Guinea (approximately 100,000 doses), Samoa (approximately 100,000 doses), Solomon (approximately 60,000 doses), Tonga (approximately 40,000 doses), Vanuatu (approximately 50,000 doses) and Iran (approximately 2,900,000 doses)